Insider · CIK 0001619252
Edward Miller
Files at KLRS (Kalaris Therapeutics, Inc.). First filing Oct 23, 2024, latest Feb 24, 2025.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
KLRS: Kalaris Therapeutics, Inc.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 30Weak | Kalaris Therapeutics, Inc. | $1,068 106 shares | -2% | - | |
| 30Weak | Kalaris Therapeutics, Inc. | $494 52 shares | -1% | - | |
| 30Weak | Kalaris Therapeutics, Inc. | $180 409 shares | -0% | - | |
| 30Weak | Kalaris Therapeutics, Inc. | $237 432 shares | -0% | - | |
| 30Weak | Kalaris Therapeutics, Inc. | $1,965 2,272 shares | -1% | - | |
| 30Weak | Kalaris Therapeutics, Inc. | $1,083 1,401 shares | -1% | - |
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Feb 21, 2025 | KLRS Kalaris Therapeutics, Inc. | SOpen-market sale Common Stock | -106 | $10.08 | $1,068 | 6,517 | Feb 24, 2025 |
| Jan 23, 2025 | KLRS Kalaris Therapeutics, Inc. | SOpen-market sale Common Stock | -47 | $9.45 | $444 | 6,628 | Jan 27, 2025 |
| Jan 23, 2025 | KLRS Kalaris Therapeutics, Inc. | SOpen-market sale Common Stock | -5 | $9.94 | $50 | 6,623 | Jan 27, 2025 |
| Jan 10, 2025 | KLRS Kalaris Therapeutics, Inc. | SOpen-market sale Common Stock | -409 | $0.44 | $180 | 153,541 | Jan 13, 2025 |
| Dec 11, 2024 | KLRS Kalaris Therapeutics, Inc. | GGift Common Stock | -57,549 | $0.00 | $0 | 153,950 | Dec 11, 2024 |
| Dec 11, 2024 | KLRS Kalaris Therapeutics, Inc. | GGift Common Stockindirect: See footnote | +57,549 | $0.00 | $0 | 346,348 | Dec 11, 2024 |
| Nov 19, 2024 | KLRS Kalaris Therapeutics, Inc. | SOpen-market sale Common Stock | -432 | $0.55 | $237 | 211,499 | Nov 20, 2024 |
| Nov 5, 2024 | KLRS Kalaris Therapeutics, Inc. | SOpen-market sale Common Stock | -2,272 | $0.86 | $1,965 | 211,931 | Nov 6, 2024 |
| Oct 21, 2024 | KLRS Kalaris Therapeutics, Inc. | SOpen-market sale Common Stock | -635 | $0.78 | $495 | 214,969 | Oct 23, 2024 |
| Oct 22, 2024 | KLRS Kalaris Therapeutics, Inc. | SOpen-market sale Common Stock | -766 | $0.77 | $588 | 214,203 | Oct 23, 2024 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.